BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25277182)

  • 21. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.
    Deng J; Liang H; Dong Q; Hou Y; Xie X; Yu J; Fan D; Hao X
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25008234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
    Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
    PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
    Hütter G; Kaiser M; Neumann M; Mossner M; Nowak D; Baldus CD; Gökbuget N; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2011 May; 35(5):614-9. PubMed ID: 21156323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
    Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
    Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events.
    Nissar B; Kadla SA; Wani KA; Shah IA; Ganai BA
    Mol Biol Rep; 2021 Jan; 48(1):405-412. PubMed ID: 33394233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
    Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
    Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
    Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
    Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
    Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
    Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
    Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
    Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
    Kang GH; Lee S; Shim YH; Kim JC; Ro JY
    Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Park SY; Kang GH
    Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
    Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
    Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
    Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
    Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
    [No Abstract]   [Full Text] [Related]  

  • 36. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
    Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
    Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.